ADAM10 and early-onset autosomal dominant Alzheimer disease: The role of certain ADAM10 substrates in disease progression suggests that ADAM10 is a promising therapeutic target, with notable possibilities for Alzheimer’s disease, cancer, and inflammatory diseases [20,21].